121 related articles for article (PubMed ID: 12946437)
1. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains.
Sabhnani L; Manocha M; Tomar D; Shashikiran D; Rao DN
Int Immunopharmacol; 2003 Oct; 3(10-11):1413-8. PubMed ID: 12946437
[TBL] [Abstract][Full Text] [Related]
2. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
Khan AA; Babu JP; Gupta G; Rao DN
Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
[TBL] [Abstract][Full Text] [Related]
3. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
Tripathi V; Chitralekha KT; Bakshi AR; Tomar D; Deshmukh RA; Baig MA; Rao DN
Vaccine; 2006 Apr; 24(16):3279-89. PubMed ID: 16476510
[TBL] [Abstract][Full Text] [Related]
4. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody for the specific diagnosis of plague.
Williams JE; Gentry MK; Braden CA; Tyndal GL; Altieri PL; Berman S; Robinson DM
Bull World Health Organ; 1988; 66(1):77-82. PubMed ID: 3260145
[TBL] [Abstract][Full Text] [Related]
7. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.
Elvin SJ; Williamson ED
Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741
[No Abstract] [Full Text] [Related]
8. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
[TBL] [Abstract][Full Text] [Related]
10. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
Elvin SJ; Williamson ED
Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
[TBL] [Abstract][Full Text] [Related]
11. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
[TBL] [Abstract][Full Text] [Related]
12. Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response.
Thomas RE; Simpson WJ; Perry LL; Schwan TG
Am J Trop Med Hyg; 1992 Jul; 47(1):92-7. PubMed ID: 1386197
[TBL] [Abstract][Full Text] [Related]
13. [Clone expression of the caf1 gene of Yersinia pestis and immunological evaluation on recombinant F1 antigen].
Wang P; Shi GX; Wang HB; Yu DZ; Zhang JZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jan; 31(1):69-72. PubMed ID: 20302703
[TBL] [Abstract][Full Text] [Related]
14. Small protective fragments of the Yersinia pestis V antigen.
Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
[TBL] [Abstract][Full Text] [Related]
15. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.
Li B; Jiang L; Song Q; Yang J; Chen Z; Guo Z; Zhou D; Du Z; Song Y; Wang J; Wang H; Yu S; Wang J; Yang R
Infect Immun; 2005 Jun; 73(6):3734-9. PubMed ID: 15908403
[TBL] [Abstract][Full Text] [Related]
16. Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive.
Brandler P; Saikh KU; Heath D; Friedlander A; Ulrich RG
J Immunol; 1998 Oct; 161(8):4195-200. PubMed ID: 9780193
[TBL] [Abstract][Full Text] [Related]
17. [Study of protective properties of antigen-containing liposomes of different lipid composition in plague].
ZakrevskiÄ VI; Plekhanova NG
Vestn Akad Med Nauk SSSR; 1990; (8):41-4. PubMed ID: 2275277
[TBL] [Abstract][Full Text] [Related]
18. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge.
Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R
Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
[TBL] [Abstract][Full Text] [Related]
20. Detection and isolation of Yersinia pestis without fraction 1 antigen by monoclonal antibody in foods and water.
Zhao T; Zhao P; Doyle MP
J Food Prot; 2012 Sep; 75(9):1555-61. PubMed ID: 22947461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]